Senator McConnell Prods FDA Regarding Regulation of Hemp-Derived CBD and Derivative Products
On September 17, Senate Majority Leader Mitch McConnell submitted language into a congressional spending report which will force the FDA to reveal their policy on hemp-derived CBD enforcement sooner rather than later. If approved by the Senate, the amended spending report could provide clarity for industry stakeholders and banks on the sidelines who eagerly await participation in the hemp-derived CBD
Rogoway Law Group
September 17, 2019
